University of Oxford
India’s Serum Institute seeks approval for COVID-19 vaccine
The Serum Institute of India, the world’s largest vaccine producer by volume, has sought government approval for emergency-use authorisation of the coronavirus vaccine that it has developed in partnership with the University of Oxford and British drugmaker AstraZeneca. “As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorisation for the first made-in-India vaccine, COVISHIELD,” the company CEO Adar Poonawalla tweeted on Monday. The experimental vaccine can be stored at two to eight degrees Celsius and can be distributed more easily in India, which has the world’s second-highest number of infections at 9.6 million. The company has applied to the Drugs Controller General of India (DCGI), with Poonawalla saying the vaccine will “save countless lives” witho...
Coronavirus vaccine breakthrough raises hopes of rapid global rollout
A coronavirus vaccine developed by Britain’s University of Oxford and the pharmaceutical firm AstraZeneca has shown successful results in early trials. If it is approved by regulators, the vaccine appears suitable for a fast rollout around the globe. Early analysis of trials involving 20,000 volunteers in Britain and Brazil show the vaccine is at least 62% effective after two doses. In volunteers given a different dosing regimen — a half dose, followed by a full dose — that figure rose to 90%. The average efficacy of the two dosing methods is 70%. None of those given the vaccine developed severe COVID-19 illness. Andrew Pollard, director of the Oxford Vaccine Group, said the recent successful trials of three different vaccines by Oxford-AstraZeneca, Pfizer-BioNTech and Moderna, represent a...
Gold rises on renewed US stimulus hope, dollar falls
Spot gold rose 0.3 percent to $1,910.56 an ounce at 3:37pm, New York time, after falling as much as 0.5 percent. Gold rose on renewed optimism for a preelection aid package in the U.S., while the dollar fell to a one-week low. House Speaker Nancy Pelosi said a bill for a compromise stimulus package is being written as she awaits a key phone call with Treasury Secretary Steven Mnuchin. Senate Majority Leader Mitch McConnell said his chamber would take up a comprehensive coronavirus package if an accord is struck. The Bloomberg Dollar Spot Index headed for the third straight decline. Pelosi said in a Bloomberg Television interview that while there are areas where more work is required to get a compromise, she was pleased with the Trump administration’s latest position on coronavirus testing ...
UK education academy confers prestigious senior fellowship on Nigerian born academic
A UK-based Nigerian academic from Osun State and Chairman of TEXEM UK, Dr Alim Abubakre has been awarded UK’s prestigious Senior Fellowship of the Advanced Higher Education Academy (HEA). According to a statement on Tuesday from TEXEM’s website signed by Caroline Lucas, this followed a rigorous review of Abubakre’s impressive record of accomplishment of contributing to advancing Executive Development in the UK, Africa and North America. He was subsequently adjudged worthy and conferred with the UK’s prestigious Senior Fellowship of the HEA which is the UK’s Gold standard in pedagogy. The senior HEA fellowship is also a UK national recognition for leadership, excellence, expertise and commitment to professionalism in teaching and learning. Abubakre has been able to present a thorough unders...
Two coronavirus vaccines proven safe for human – research
Two coronavirus vaccine have proven safe for humans and produced strong immune reactions among patients involved in separate clinical trials, doctors said Monday. The first trial among more than 1,000 adults in Britain found that the vaccine-induced “strong antibody and T cell immune responses” against the novel coronavirus. A separate trial in China involving more than 500 people showed most had developed widespread antibody immune response. The studies, published in The Lancet medical journal, constitute a major step on the road towards a COVID-19 vaccine that is effective and safe for widespread use. The authors of the studies said that they encountered a few adverse side effects from the vaccine candidates. However, they cautioned that more research was needed, particularly among older...
